carbon group molecular entity etodolac InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20) (+-)-1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid Drug_Central:1103 KEGG:D00315 CHEBI:126431 Patent:US3939178 PMID:2970548 A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active. LINCS:LSM-1781 HMDB:HMDB0014887 PMID:15369391 CCc1cccc2c3CCOC(CC)(CC(O)=O)c3[nH]c12 NNYBQONXHNTVIJ-UHFFFAOYSA-N 287.35350 DrugBank:DB00749 PMID:28166217 1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid etodolacum (1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid 287.15214 CHEBI:4909 chebi_ontology (1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid CAS:41340-25-4 PMID:2527995 Patent:DE2301525 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid Wikipedia:Etodolac C17H21NO3 ETODOLAC etodolac 1,3,4,9-tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid etodolaco 0 ETODOLIC ACID